Like many industries, cannabis-related companies in the United States haven’t been left untouched by the fallout from the coronavirus. On the bright side, demand for cannabis products swelled in the initial weeks following government-mandated lockdowns.
“New Frontier Data reported that in March, cannabis spending grew up to 20% across all categories, whether it be flower, edibles, topicals, and the like,” said David Kennedy (pictured above), founder and CEO at Purple Risk Management Services. “The rationale was that people were stockpiling, thinking that there were going to be long-term, stay-at-home quarantine orders.”
You've reached your limit - Register for free now for unlimited access
To read the full story, and get unlimited access to Insurance Business website content, just register for free now. GET STARTED HERE
Already a website member? Log in below.